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ABSTRACT* 
The Beers criteria (2003) and McLeod criteria 
(1997) have been applied internationally to quantify 
inappropriate prescribing in elderly populations. 
Similarly, guidelines have been published locally by 
the National Prescribing Service (NPS).  
Objective: This study aimed to adapt, evaluate and 
compare the utility of these three established criteria 
in measuring prescribing appropriateness in a 
sample of hospitalised elderly patients.  
Methods: Initial refinement of the criteria produced 
versions applicable to Australian practice. Inpatient 
records of 202 patients aged 65 years or older in six 
wards of the Princess Alexandra Hospital, Brisbane, 
Australia, were reviewed using the adapted criteria. 
‘Potentially inappropriate’ prescribing was 
descriptively analysed using relevant denominators. 
Results: The adapted criteria collectively listed 70 
‘potentially inappropriate’ medicines or drug groups 
and 116 ‘potentially inappropriate’ prescribing 
practices. Patients (mean age 80.0; SD=8.3 years) 
were prescribed, a median of eight medicines 
(SD=4.0). At least one ‘potentially inappropriate’ 
medicine was identified in 110 (55%) patients. 
‘Potentially inappropriate’ prescribing practices 
averaged 1.1 per patient (range 1-6). The adapted 
Beers criteria identified more ‘potentially 
inappropriate’ medicines/practices (44%, 101/232) 
than the McLeod criteria (41%) and NPS criteria 
(16%). Aspirin, benzodiazepines, beta-blockers and 
dipyridamole were most commonly identified. 
Conclusion: The Beers and McLeod criteria, 
developed internationally, required considerable 
modification for local prescribing. The three criteria 
differed in their focus and approaches, such that 
development and validation of national criteria, 
using the key features of these models, is 
recommended. There is potential to apply validated 
guidelines in clinical practice and review of 
prescribing, but only to supplement clinical 
judgement. 
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COMPARACIÓN DE LOS CRITERIOS DE 
PRESCRIPCIÓN EN ANCIANOS 
HOSPITALIZADOS EN AUSTRALASIA 
 
RESUMEN 
Los criterios de Beers (2003) y los criterios de 
McLeod (1997) han sido aplicados 
internacionalmente para cuantificar la prescripción 
inapropiada en las poblaciones de ancianos. 
Asimismo, el Natioanl Prescribing Service (NPS) 
ha publicado guías locales. 
Objetivo: Este estudio trató de adaptar, evaluar y 
comparar la utilidad de estos tres criterios 
establecidos para medir la prescripción inapropiada 
en una muestra de pacientes ancianos 
hospitalizados. 
Métodos: Un afinamiento inicial de los criterios 
produjo versiones aplicables a la práctica 
Australiana. Se recogieron los historiales de 202 
pacientes hospitalizados de 65 o más años en seis 
servicios del Hospital Princess Alexandra de 
Brisbane, Australia y se utilizaron los criterios 
adaptados. Se analizó descriptivamente la 
prescripción ‘potencialmente inapropiada’ 
utilizando denominadores relevantes. 
Resultados: Los criterios adaptados incluían 
colectivamente 70 medicamentos o grupos 
‘potencialmente inapropiados’ y 116 prácticas de 
prescripción ‘potencialmente inapropiadas’. A los 
pacientes (edad media 80,0; DE=8,3 años) se les 
prescribió una media de ocho medicamentos 
(DE=4,0). Se identificó al menos un medicamento 
‘potencialmente inapropiado’ en 110 (55%) 
pacientes. Las prácticas de prescripción 
‘potencialmente inapropiadas’ promediaron 1,1 por 
paciente (rango 1-6). Los criterios de Beers 
adaptados identificaron más 
medicamentos/prácticas ‘potencialmente 
inapropiadas’ (44%, 101/232) que los de McLeod 
(41%) y NPS (16%). Los más comúnmente 
identificados fueron aspirina, benzodiacepinas, 
beta-bloqueantes y dipiridamol. 
Conclusión: Los criterios de Beers y McLeod, 
desarrollados internacionalmente, requieren una 
considerable modificación para la prescripción 
local. Los tres criterios diferían en su objetivo y 
abordajes, de modo que se recomienda el desarrollo 
y validación de criterios nacionales, utilizando los 
puntos clave de estos modelos. Existe la 
oportunidad de aplicar guías validadas en la 
práctica clínica y revisión de la prescripción, pero 
sólo para suplementar el juicio clínico. 
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INTRODUCTION 
The proportion of Australians aged 65 years and 
over is estimated to increase from 12% in 1999 to 
around 25% by 2051.1 Older patients necessitate 
vigilance in prescribing due to their number of 
medical conditions and medications.2,3 
Internationally, ‘inappropriate prescribing’, a 
recognised problem in the elderly, has been 
modelled to quantify and reduce these issues. 
Beers et al.4 published criteria in the United States 
in 1991 to determine potentially inappropriate 
prescribing of medication. The revised version 
(2003)5 categorises listed 48 medicines or drug 
classes that should generally be avoided in elderly 
patients. Despite acceptance and international 
application of the Beers criteria, continual updating 
and international tailoring are required.3,6,7 The 
Beers criteria are explicit in nature, being derived 
from published reviews, expert opinions and 
consensus techniques without clinical judgement 
about the presenting patient.8 Studies report 7.8%9 
to over 50%3,10 of patients with at least one 
potentially inappropriate medication, dependent on 
research design (retrospective versus prospective 
reviews) and characteristics of the reference 
patients and setting (primary care, secondary care, 
continuing care).  
The McLeod criteria,11 a Canadian initiative, were 
developed following the Beers criteria 1991, based 
on risk-benefit ratios, drug-drug interactions and 
drug-disease interactions, and describing 38 
prescribing practices (across four drug/disease 
groups: drugs to treat cardiovascular disease, 
psychotropic drugs, non-steroidal anti-inflammatory 
drugs, and other analgesics and miscellaneous 
drugs), again rated through expert consensus to 
produce a significance rating up to 4.00, as 
opposed to the ‘high’ and ‘low’ significance 
categories of the Beers criteria. 
As with the Beers criteria, the McLeod criteria have 
been criticised for their limited applicability to 
geriatric clinical practice.3 A revision, the Improved 
Prescribing in the Elderly Tool (IPET)3,12 was trialled 
in Ireland and compared to the Beers criteria to 
quantify rates of inappropriate prescribing in 
hospitals. The Beers criteria demonstrated superior 
sensitivity via a more exhaustive list of drugs, 
despite some being considered obsolete or rarely 
used.13  
Further international research has produced the 
START (Screening Tool to Alert doctors to Right 
Treatment) and STOPP (Screening Tool of Older 
Persons’ Prescriptions) criteria.3,14 While these 
criteria show promise, their international applicability 
has not been established.3 
Several studies have merged the Beers and 
McLeod criteria to determine their combined and 
relative sensitivity.15-17 Australian data applying both 
criteria are limited to analysis of Department of 
Veterans’ Affairs pharmacy claims, in which 26 
inappropriate medicines were identified.18 The 
database excluded information about diagnosis, 
dosage and duration, requiring exclusion of some 
indicators of these criteria. 
The only nationally-endorsed criteria specific to 
Australian prescribing exist in the National 
Prescribing Service (NPS) indicators for quality 
prescribing in Australian general practice, published 
in 2006.19 These evidence-based criteria, designed 
for self-review of prescribing by general 
practitioners, describe quality prescribing via 
structure, process and outcome indicators, the 
process indicators detailing prescribing situations 
requiring caution in older patients. No published 
studies of their application have been located.  
The Commonwealth Department of Veterans’ 
Affairs produced a Therapeutic Brief No. 8 - 
Reducing Adverse Drug Events for your Veteran 
Patients for use by general practitioners. Although 
these guidelines were developed from both the 
Beers and McLeod criteria, details of their 
development are lacking, and the resulting criteria 
listed only four medication groups (long-acting 
benzodiazepines, anticholinergics, non-steroidal 
anti-inflammatories and a miscellaneous category) 
to guide patient management.2 
Other developments have been reported following 
research in Victorian hospitals nearly 10 years ago, 
producing 19 prescribing indicators specific to 
hospitalised elderly.20,21 These criteria demonstrated 
some potential, but they were not adopted more 
widely to gain national endorsement. More recently, 
researchers in Australia7 have matched the most 
common reasons for treatment in the elderly with 
the most commonly prescribed medicines, 
incorporating precautions from the Australian 
Medicines Handbook.22 This research produced 
locally-relevant criteria, although it rejected 
consensus methodology, and in deriving the list, 
equated most commonly prescribed medicines with 
‘most appropriate’ prescribing.7 
In summary, the Beers and McLeod criteria, with 
their limited applicability to Australian practice, 
appear to be the most established tools for 
measurement of prescribing to the elderly. The 
Australian equivalent in terms of scope and national 
endorsement is the NPS criteria, although 
alternatives have been reported for specific 
purposes. With the increasing elderly population in 
Australia, and the risks associated with multiple 
medicine use in this population, it is timely to 
investigate the utility of these models in the 
Australian context, recognising that prescribing 
criteria serve as a guide only and do not replace 
clinical judgement. 
 
METHODS  
This study aimed to refine, apply and evaluate the 
utility of the Beers criteria 2003, the McLeod criteria 
1997 and NPS criteria in a sample of hospitalised 
elderly patients in Australia. ‘Utility’ was defined as 
relevance of listed medications (or drug groups) to 
Australian prescribing and the interpretability of the 
criteria with respect to available patient records. 
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Refinement of the Prescribing Criteria 
The Beers, McLeod and NPS criteria were initially 
refined by one of the researchers (WP) by removing 
drugs unavailable in Australia.19,22 This approach 
has been applied elsewhere.3,22,23 Refinement of the 
Beers criteria resulted in retention of 57 medicines 
(63%). For the McLeod criteria, 33 of the 38 
potentially inappropriate practices were determined 
relevant to Australian practice. The majority of the 
NPS criteria were worded as best-practice 
statements, rather than indicators of inappropriate 
medication prescribing; four of the 21 indicators of 
‘potentially inappropriate’ prescribing were retained 
for this study. These related to prescribing of 
antibiotics for upper respiratory tract infections, 
prescribing of cephalexin for various conditions, 
prescribing of ACE inhibitors with diuretics and non-
steroidal anti-inflammatory drugs (known as the 
‘triple whammy’), and long-term prescribing of 
benzodiazepines. 
The merged criteria comprised: 
• 70 medications or drug groups (13 medications 
were common to both the Beers and the McLeod 
criteria), and 
• 116 ‘inappropriate’ prescribing practices – 
medications or drug groups that should generally 
be avoided in the elderly or are considered 
inappropriate in particular conditions – 79 from the 
Beers criteria, 33 from the McLeod criteria and 
four from the NPS criteria. 
The refined criteria were programmed into an Excel 
spreadsheet designed to also record patient codes, 
ward, medicines and medical conditions. 
Data Collection 
This study was conducted in the Princess Alexandra 
Hospital (PAH), a 727-bed public hospital in 
Brisbane. Six wards containing a significant 
proportion of the hospital’s elderly patients, and 
comprising three general medical wards (averaging 
two patient admissions per day per ward, total 80 
beds) and three rehabilitation wards (averaging 0.5 
patient admissions per day per ward, total 78 beds), 
were selected.  
Ethical approval was obtained from the Health and 
Research Ethics Committee of the PAH prior to data 
collection. Informed consent of the patients was not 
required, due to their de-identification and lack of 
direct involvement. 
Patients aged 65 years and older, on any regular 
prescribed medication, were included. Reason for 
admission did not affect their eligibility for inclusion. 
The target sample size was determined via initial 
data collection involving 70 patients, with statistical 
projection to determine differences between 
preliminary rates of ‘inappropriate’ prescribing (6.2% 
and 4.3%, the two closest proportions, at alpha=0.5 
and 95% power). This approach indicated recording 
of 1478 medications, or 154 patients at 9.6 
medications per patient. At the rate of data 
collection of one ward per day for data collection 
followed by six admissions per day, a total of 263 
records could be collected over one month less 
weekends (19 days). Losses due to inaccessibility, 
ineligibility, early discharge, and admission or 
discharge on non-research days were expected. 
Consequently, 19 data collection days were 
retained (March-April, 2007). The first three days 
comprised pilot testing, which identified minor 
improvements requiring limited retrospective 
supplementation of the pilot data. The data 
collection comprised ‘snapshot’ chart reviews by a 
single researcher (WP) of regular and ‘as needed’ 
medications, irrespective of the source, date or 
reason of the prescription. Patients who were either 
present or admitted during the data collection were 
included, and those who transferred between wards 
during the data collection were represented once 
only in the database, with their most current 
medications reviewed by the researcher. 
Analysis 
Categorical or numerical significance ratings of the 
significance of inappropriateness were manually 
added to the database from literature describing the 
Beers, McLeod and NPS criteria. Prescribing of 
aspirin and benzodiazepines was assumed to be for 
continuing use. The Beers criteria considered 
aspirin as inappropriate at any dose in patients 
receiving anticoagulants, and at doses of at least 
325mg as inappropriate in patients with a history of 
gastric ulceration. The McLeod criteria made no 
distinction regarding aspirin doses. 
Analysis comprised descriptive comparison and 
critique of the three criteria to determine their 
respective ‘utility’, and prevalence data for 
prescribing appropriateness, according to the three 
criteria (using SPSS version 13.0). Denominators 
were the number of patients and the total number of 
prescribed medications. 
 
RESULTS  
Description of the Study Sample 
During the study period, 296 patients were present 
in, or admitted to, the six wards. Eighty-seven were 
excluded due to age (<65 years), and seven 
patients’ records were unavailable. The records of 
the 202 patients listed 1794 prescribed medications, 
a median of eight medications per patient (SD=4.0, 
maximum 22). 
The mean age was 80.0 (SD=8.3) years (range 65-
99 years). The dominant group was females aged 
85-89 years (n=39). The three General Medical 
wards each contributed 37-45 patients to the study, 
while the three Rehabilitation wards each 
contributed 23-33 patients, reflecting the higher 
turnover of the General Medical wards. Some 
patients transferred between General Medical and 
Rehabilitation wards during the study. 
‘Inappropriate’ Prescribing (per Patient) 
The merged criteria identified 232 ‘potentially 
inappropriate’ medications prescribed, averaging 
1.1 potential issues per patient. The Beers criteria 
detected a mean of 0.5 potential cases of 
inappropriate prescribing per patient, compared to 
0.47 using the McLeod criteria and 0.18 using the 
NPS criteria.
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Table 1: Instances of ‘Potentially Inappropriate’ Prescribing (202 patient records) 
Medicines/Drug Groups Identified Conditions Beers McLeod NPS 
Amiodarone   7 0 0 
Amitriptyline   2 0 0 
Syncope/fall 1 0 0 
Cognitive impairment 3 0 0 
Constipation 1 0 0 Anticholinergics 
Incontinence 1 0 0 
Antipsychotics Parkinsons 1 0 0 
Aspirin Receiving anticoagulants 36 0 0 
Aspirin Hypertension 0 47 0 
Antibiotics Upper respiratory tract infect. 0 0 3 
Benzodiazepines   0 0 26 
Angina and COPD 0 1 0 
Angina and heart failure 0 6 0 
Hypertension and COPD 0 6 0 Beta-blockers 
Hypertension and heart failure 0 13 0 
Calcium channel blockers Constipation 4 0 0 
  Hypertension and heart failure 0 4 0 
Cephalexin   0 0 1 
Clopidogrel Receiving anticoagulants 5 0 0 
Diazepam   5 0 0 
Digoxin >125mcg   1 0 0 
Receiving anticoagulants 2 0 0 Dipyridamole Stroke 0 13 0 
Doxepin   2 0 0 
Imipramine Arrhythmia 2 0 0 
Methyldopa   1 0 0 
Muscle relaxants Cognitive impairment 1 0 0 
Nifedipine   4 0 0 
NSAIDs (non-aspirin) Hypertension 0 2 0 
Oestrogen only   2 0 0 
Oral steroid Diabetes and COPD 0 1 0 
Oxazepam >60mg   2 0 0 
Oxybutynin   3 0 0 
Promethazine   1 0 0 
Propanolol COPD 1 0 0 
Short-intermediate acting+fall Syncope/Fall 2 0 0 
SSRIs SIADH/Hyponatraemia 4 0 0 
Constipation 1 0 0 
Depression 0 1 0 Tricyclic antidepressants 
Syncope/Fall 1 0 0 
Temazepam >15mg   5 0 0 
‘Triple Whammy’   0 0 7 
Total   101 94 37 
 
Table 2: Most Commonly Identified Inappropriate Medications (202 patient records)  
Medication McLeod Beers NPS Total 
Aspirin 47 36 0 83 
Benzodiazepines 0 14 26 40 
Beta-blockers 26 0 0 26 
Dipyridamole 13 2 0 15 
 
In total, 110 patients (55%) had been prescribed at 
least one ‘potentially inappropriate’ medication 
according to the amalgamated criteria, ranging from 
one to six instances per patient. 
There was no significant difference in the 
proportions of patients with at least one 
‘inappropriate’ medication detected by any of the 
three criteria between the Rehabilitation and 
Medical wards (p>0.05). 
‘Inappropriate’ Prescribing (by Medicine and Drug 
Group) 
Of the 232 potential issues detected (in 110 
patients), 101 issues (44%) were identified by the 
Beers criteria, 94 issues (41%) by the McLeod 
criteria and 37 issues (16%) by the NPS criteria 
(Table 1). There was no overlap in the components 
of the three criteria, and therefore each of the 
issues identified was discrete. The combined criteria 
identified the most common ‘inappropriate’ 
medications as aspirin and benzodiazepines (Table 
2).  
Of the 101 issues identified using the refined Beers 
criteria, 88 were classified as ‘high’ significance and 
13 as ‘low’ significance issues. Thirty-six of the 
issues related to the prescription of aspirin in 
patients who concurrently received anticoagulant 
therapy (‘high’ significance). Of the 94 issues 
detected using the McLeod criteria, the highest 
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prevalence was again attributed to the prescribing 
of aspirin, which was classified with non-steroidal 
anti-inflammatory drugs, in patients with history of 
hypertension. The median significance rating (of a 
maximum of 4) was 3.35.  
The NPS identified that prescribing in specific 
circumstances was with ‘caution’, rather than 
assigning significance. Benzodiazepines use in the 
elderly was the most common potential problem 
identified (26 of the 37 issues).  
 
DISCUSSION 
Discussion of the Method 
Numerous trials of the Beers criteria and a 
combination of the Beers and McLeod criteria were 
hospital based.10,15,16,23-25 Despite the mix of 
patients admitted to these wards, the findings from 
the selected wards in one hospital cannot be 
extrapolated to other wards in the hospital or the 
broader community. Future studies, however, are 
feasible to extend and validate this method. While 
our study reported a comparison of the Beers, 
McLeod and NPS criteria, amalgamation of the 
relevant features is the next logical step towards 
producing a set of criteria for use in Australian 
practice. 
The preliminary data for 70 patients indicated a 
median of nine medicines per patient, whereas the 
final data from 202 records (including the pilot 
sample) identified a median of eight medicines per 
patient. Although the magnitude of this difference 
did not compromise the final sample size, the 
variability should be noted for future research. 
Previous studies have reported the proportion of 
patients receiving at least one inappropriate drug 
prescription.9,10,15,23,24 Our study presented 
‘potentially inappropriate’ issues detected per 
patient and inappropriate issues detected by 
medicine or drug group. The two denominators 
provide alternative views of the prevalence and 
nature of potential inappropriate prescribing.  
Utility of the Refined Criteria 
Utility was defined here as the relevance of the 
listed medications (or drug groups) to Australian 
prescribing and the interpretability of the criteria. 
Revision and numerous assumptions about the 
context of prescribing were required for all three 
criteria, and interestingly, there was limited 
commonality in the listed medicines (or drug 
groups). Although the majority of the constituent 
indicators was relevant to local practice and 
therefore retained, one recommendation from this 
study is to extend other local research to customise 
and validate a set of criteria for subsequent use in 
Australia. 
Of the three criteria, the Beers criteria required the 
most refinement, due to the listing of specific 
medicines available in America but not in Australia. 
On this basis, it could be considered to have the 
lowest utility of the three criteria, but its sensitivity 
was superior, in detecting the highest proportion of 
all potential prescribing issues and the greatest 
number of issues per patient. The incidence of 
inappropriate prescribing detected by the Beers 
criteria (44% of the identified issues) and McLeod 
criteria (41%) were somewhat higher than those of 
previous research (17% and 11%, respectively), in 
which only part one of the Beers criteria were 
included.17 
The list of medication groups in the McLeod criteria 
is an advantage over the Beers and NPS criteria in 
terms of international applicability. The major 
limitation for application of the McLeod criteria was 
the need for patient-specific information concerning 
the indication, duration of prescription and co-
morbidities. Difficulty in obtaining these data have 
been noted elsewhere.16,17 An intermediate level of 
clinical knowledge was also required to associate 
prescribed medicines with the listed drug groups. 
Although the NPS criteria were developed in 
Australia, the refined version only identified four 
indicators of prescribing appropriateness. The 
proportion of issues identified by the NPS criteria 
might not contribute significantly to the overall 
findings. However, the advantage of these criteria 
was their foundation in published literature. 
Amalgamation with the Beers and McLeod criteria is 
the obvious recommendation for further 
development.  
In the absence of data about the intended duration 
of therapy, medications were conservatively 
assumed to be for continuing use, which may have 
over-represented the prescribing issues for patients 
taking benzodiazepines. Lack of information about 
the intended use of aspirin and co-morbidities may 
have resulted in over-estimation of the potential 
issues surrounding its use. By their nature, 
however, it may be assumed that these criteria offer 
an estimation of prescribing appropriateness, to be 
potentially overridden by clinical judgement. 
The proportion of patients who received at least one 
inappropriate prescription in our study (55%) was 
consistent with two other studies citing 40% and 
46% of patients, respectively, receiving at least one 
potentially inappropriate drug prescription.15,16 
However, a European study, in which the Beers and 
McLeod criteria were amalgamated, reported this 
figure at 20%.17 International differences in 
prescribing practices and health care systems may 
invalidate such comparisons. We would expect our 
results to be similar to other hospitals in Australia, 
and higher than data reported from ambulatory 
studies due to the nature of the hospitalised study 
population. Newly-developed prescribing criteria, 
such as the STOPP/START criteria14, may also be 
integrated into Australian research in the same 
manner as the international criteria applied in this 
study. 
The practices identified by these criteria as 
‘inappropriate’ may indeed have been clinically 
sound, following unsuccessful alternatives or the 
consideration of risks in individuals, i.e. the use of 
implicit (patient-specific) criteria. These situations 
are largely undocumented and were unable to be 
embraced in this or similar studies.  
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CONCLUSIONS 
The intention of these prescribing criteria is to 
identify situations requiring consideration, rather 
than replace clinical judgement. Further 
customisation and application of criteria are 
recommended to produce validated guidelines for 
use in clinical practice and prescribing reviews in 
the care of elderly patients in Australia.  
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